杭肿用CRISPR修改丅细胞基因,以免疫方式在临床治疗食道癌病人,有初步效果,定论尚早。报道见内

来源: 2018-02-21 05:22:48 [博客] [旧帖] [给我悄悄话] 本文已被阅读:

https://www.npr.org/sections/health-shots/2018/02/21/585336506/doctors-in-china-lead-race-to-treat-cancer-by-editing-genes